Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Needham

CBRS Stock Watch: Cerebras Soars as Analysts Issue 'Buy' Ratings

Wall Street analysts initiate bullish sentiment on Cerebras stock. Here’s why they believe CBRS shares will rip higher from here as the year unfolds.

Barchart

Omar Kelly: Things we learned in the first week of Dolphins training camp

The first week of training camp is in the books, and the Mike McDaniel era of the Miami Dolphins franchise began about as smoothly as it could have possibly gone.

Tribune News Service

Needham Says Merus' ASCO Update On Zeno 'Positive'

Needham writes that Merus NV (NASDAQ: MRUS) has enough data to initiate an FDA marketing application filing in mid-2022 after presenting Zenocutuzumab (Zeno) data in NRG1-fusion (NRG1+) Cancer.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.